Pedro Marques da Silva

Summary

Country: Portugal

Publications

  1. ncbi Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan
    Pedro Marques da Silva
    Núcleo de Investigação Arterial, Medicina IV Hospital de Sta Marta, CHLC, EPE, Lisbon, Portugal
    Clin Drug Investig 30:625-41. 2010
  2. ncbi [Intensive cholesterol drug lowering: how to be sure about their safety]
    Pedro Marques da Silva
    Unidade Funcional Medicina IV do Hospital de Santa Marta Centro Hospitalar de Lisboa Central, EPE, Lisboa, Portugal
    Rev Port Cardiol 29:1405-18. 2010
  3. ncbi Are all statins the same? Focus on the efficacy and tolerability of pitavastatin
    Pedro Marques da Silva
    Núcleo de Investigação Arterial, Medicina IV Hospital de Sta Marta, CHLC, EPE, Lisbon, Portugal
    Am J Cardiovasc Drugs 11:93-107. 2011

Detail Information

Publications3

  1. ncbi Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan
    Pedro Marques da Silva
    Núcleo de Investigação Arterial, Medicina IV Hospital de Sta Marta, CHLC, EPE, Lisbon, Portugal
    Clin Drug Investig 30:625-41. 2010
    ....
  2. ncbi [Intensive cholesterol drug lowering: how to be sure about their safety]
    Pedro Marques da Silva
    Unidade Funcional Medicina IV do Hospital de Santa Marta Centro Hospitalar de Lisboa Central, EPE, Lisboa, Portugal
    Rev Port Cardiol 29:1405-18. 2010
    ..The grounds for treatment and intensive effective reduction of dyslipidemias must be made through a better adherence to quality Health Programs and through improving treatment and achieved goals...
  3. ncbi Are all statins the same? Focus on the efficacy and tolerability of pitavastatin
    Pedro Marques da Silva
    Núcleo de Investigação Arterial, Medicina IV Hospital de Sta Marta, CHLC, EPE, Lisbon, Portugal
    Am J Cardiovasc Drugs 11:93-107. 2011
    ..The combination of a potent decrease in total and LDL cholesterol levels and increase in HDL cholesterol levels suggest that pitavastatin may produce substantial cardiovascular protection...